Cell-surface expression of H-2Db requires N-linked glycans

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Beta-2 microglobulin (B2m) is crucial for the cell-surface expression of most mouse major histocompatibility complex (MHC) class I antigens.
• The H-2Db molecule, an MHC class I antigen, exhibits unusual cell-surface expression independent of B2m.

Purpose of the Study:

• To investigate the role of glycosylation in the B2m-independent cell-surface expression of the H-2Db molecule.
• To determine if the atypical glycosylation pattern of H-2Db contributes to its unique expression characteristics.

Main Methods:

• Transfection of H-2Db into B2m-deficient R1E cells.
• Treatment with tunicamycin (Tm) to inhibit glycosylation.
• Expression analysis of wild-type and truncated H-2Db molecules.
• Introduction of a functional B2m gene into R1E cells.

Main Results:

• Tunicamycin treatment abolished cell-surface expression of H-2Db in B2m-deficient cells, indicating glycosylation is essential.
• Reintroduction of B2m did not restore H-2Db expression in the presence of tunicamycin.
• A truncated H-2Db molecule, glycosylated at position 256, showed no sensitivity to tunicamycin, suggesting domain-specific conformational requirements.
• Glycosylation appears to stabilize the alpha 1 and/or alpha 2 domains of H-2Db, facilitating cell-surface transport.

Conclusions:

• The unusual B2m-independent cell-surface expression of H-2Db is primarily mediated by its unique glycosylation pattern.
• Glycans confer a stable conformation to the H-2Db molecule, enabling its transport and presentation on the cell surface even without B2m.
• This study highlights the critical role of post-translational modifications, specifically glycosylation, in MHC molecule stability and function.